Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dose-finding for cough prevention during extubation
IRCT20090129001615N8Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of dexmedetomidine (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Frequency of coughing during extubation and Intensity of coughing during extubation. Started May 2023; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on IRCT20090129001615N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090129001615N8.